We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First Treatment Approved under EAMS Developed Using Antibody Humanization Expertise at UK’s MRC Technology

News   Mar 11, 2015

 
First Treatment Approved under EAMS Developed Using Antibody Humanization Expertise at UK’s MRC Technology
 
 
 

RELATED ARTICLES

Natural Plant Defense Genes

News

In a new study, researchers identify genes and metabolic pathways responsible for safener efficacy in grain sorghum.

READ MORE

A New Perspective on Immune and Blood Cell Production

News

Tracking and quantifying the production of different kinds of blood cells and immune cells has provided new insights on how the body maintains a balanced supply.

READ MORE

Plant Immunity Cut to Size

News

Researchers have found a link between a class of enzymes and immune signals that is rapidly triggered upon physical damage in plants.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE